Email Updates

You are here

Voluntary Medical Male Circumcision

A simple approach with life-long benefits could prevent millions of HIV infections. It’s time to realize that potential.

Voluntary medical male circumcision (VMMC) is one of the most powerful and cost-effective HIV prevention tools at hand. Studies from 2006 showed that it reduces a man’s risk of acquiring HIV from a female partner by up to 60 percent, increasing to around 75 percent over time.

VMMC is being rolled out for HIV prevention in 14 sub-Saharan African countries with high HIV prevalence and low levels of adult male circumcision. The goal: achieve 80 percent coverage among men in these countries in order to avert 3.4 million new HIV infections and save US$16.6 billion in future healthcare costs. After years of slow progress, scale-up of VMMC is accelerating. Sustained investment and close monitoring are needed to keep things on track.

Newly available non-surgical circumcision devices could also play a role, offering an alternative to sutures and surgery that some men may prefer. Countries need to decide if and how to introduce devices, while making plans, budgets and communications campaigns to keep scale-up on track. AVAC and others are advocating for action to make sure these steps happen.

What We're Reading

VMMC programme data from most of the priority countries were successfully reviewed, updated, validated and incorporated into the annual HIV Estimates process in 2020. It is important to ensure that these data continue to be used for programme planning and management. Current and future data issues will need to be addressed, and countries will need ongoing support to do so. The integration of the DMPPT2 Online into the annual HIV Estimates process is a positive step forward in terms of streamlining country-owned planning and analytical practices for the HIV response.

September 21, 2021
Subscribe to RSS - Voluntary Medical Male Circumcision